Harnessing future developments in healthcare - and broaching how to pay
This article was originally published in Clinica
Executive Summary
What does it take to lead in medical innovation? That was the challenging question thrown out to delegates at NHS Innovations London's meeting on that theme last week at Wembley stadium. There may still be more questions than answers on this, but at least the field of play - or battle - is becoming clearer, writes Ashley Yeo.
You may also be interested in...
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.
The Aspirin Test For AI?
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.
Mary Beth Clarke, CDER Exec Programs Office Director And Generic User Fee Shepherd, Will Retire
Clarke helped launch GDUFA I and negotiate GDUFA II, chaired the CDER Executive Committee and oversaw many other programs in the US FDA’s drugs center.